Marquette Asset Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Marquette Asset Management’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-54,278	Closed	-$98.2K	–	318
2023 Q2	$98.2K	Buy	+54,278	New	+$99.2K	0.02%	119

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Marquette Asset Management's PRDS Position: Q3 2023 in Review

Marquette Asset Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 54,278 shares — an estimated $98.2K sold.

Marquette Asset Management first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $98.2K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Marquette Asset Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Marquette Asset Management sold 54,278 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $98.2K.
Marquette Asset Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Marquette Asset Management's Pardes Biosciences, Inc. Common Stock position peaked at $98.2K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Marquette Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.